Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 24124660)

1.

Preoperative imaging for early-stage cutaneous melanoma: predictors, usage, and utility at a single institution.

Haddad D, Garvey EM, Mihalik L, Pockaj BA, Gray RJ, Wasif N.

Am J Surg. 2013 Dec;206(6):979-85; discussion 985-6. doi: 10.1016/j.amjsurg.2013.08.017. Epub 2013 Oct 12.

PMID:
24124660
2.

Utility of preoperative 18F-FDG PET/CT and brain MRI in melanoma patients with palpable lymph node metastases.

Aukema TS, Valdés Olmos RA, Wouters MW, Klop WM, Kroon BB, Vogel WV, Nieweg OE.

Ann Surg Oncol. 2010 Oct;17(10):2773-8. doi: 10.1245/s10434-010-1088-y. Epub 2010 Apr 27.

PMID:
20422454
3.

Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit.

Constantinidou A, Hofman M, O'Doherty M, Acland KM, Healy C, Harries M.

Melanoma Res. 2008 Feb;18(1):56-60. doi: 10.1097/CMR.0b013e3282f62404.

PMID:
18227709
4.

Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma.

Aloia TA, Gershenwald JE, Andtbacka RH, Johnson MM, Schacherer CW, Ng CS, Cormier JN, Lee JE, Ross MI, Mansfield PF.

J Clin Oncol. 2006 Jun 20;24(18):2858-65.

5.

Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma.

Singh B, Ezziddin S, Palmedo H, Reinhardt M, Strunk H, Tüting T, Biersack HJ, Ahmadzadehfar H.

Melanoma Res. 2008 Oct;18(5):346-52. doi: 10.1097/CMR.0b013e32830b363b.

PMID:
18781133
6.

Fluorodeoxyglucose-positron emission tomography imaging versus sentinel node biopsy in the primary staging of melanoma patients.

Longo MI, Lázaro P, Bueno C, Carreras JL, Montz R.

Dermatol Surg. 2003 Mar;29(3):245-8.

PMID:
12614417
7.

Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection.

Belhocine T, Pierard G, De Labrassinne M, Lahaye T, Rigo P.

Oncologist. 2002;7(4):271-8.

8.

Role of radiologic imaging at the time of initial diagnosis of stage T1b-T3b melanoma.

Yancovitz M, Finelt N, Warycha MA, Christos PJ, Mazumdar M, Shapiro RL, Pavlick AC, Osman I, Polsky D, Berman RS.

Cancer. 2007 Sep 1;110(5):1107-14.

9.

Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.

Wagner JD, Schauwecker D, Davidson D, Logan T, Coleman JJ 3rd, Hutchins G, Love C, Wenck S, Daggy J.

Cancer. 2005 Aug 1;104(3):570-9.

10.

Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy.

Wagner JD, Schauwecker D, Davidson D, Coleman JJ 3rd, Saxman S, Hutchins G, Love C, Hayes JT.

J Clin Oncol. 1999 May;17(5):1508-15.

PMID:
10334538
11.

Imaging studies in patients with melanoma.

Choi EA, Gershenwald JE.

Surg Oncol Clin N Am. 2007 Apr;16(2):403-30. Review.

PMID:
17560520
12.

Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET).

Servois V, Mariani P, Malhaire C, Petras S, Piperno-Neumann S, Plancher C, Levy-Gabriel C, Lumbroso-le Rouic L, Desjardins L, Salmon RJ.

Eur J Surg Oncol. 2010 Feb;36(2):189-94. doi: 10.1016/j.ejso.2009.08.010. Epub 2009 Sep 22.

PMID:
19775851
13.

F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.

Maubec E, Lumbroso J, Masson F, Suciu V, Kolb F, Mamelle G, Cavalcanti A, Boitier F, Spatz A, Aupérin A, Leboulleux S, Avril MF.

Melanoma Res. 2007 Jun;17(3):147-54.

PMID:
17505260
14.

PET CT imaging in patients undergoing sentinel node biopsy for melanoma.

Kell MR, Ridge JA, Joseph N, Sigurdson ER.

Eur J Surg Oncol. 2007 Sep;33(7):911-3. Epub 2007 Jan 4.

PMID:
17207956
15.

Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II.

Fink AM, Holle-Robatsch S, Herzog N, Mirzaei S, Rappersberger K, Lilgenau N, Jurecka W, Steiner A.

Melanoma Res. 2004 Apr;14(2):141-5.

PMID:
15057045
16.

Initial staging of malignant melanoma by positron emission tomography and sentinel node biopsy.

Libberecht K, Husada G, Peeters T, Michiels P, Gys T, Molderez C.

Acta Chir Belg. 2005 Nov-Dec;105(6):621-5.

PMID:
16438072
17.

Baseline staging in cutaneous malignant melanoma.

Hafner J, Schmid MH, Kempf W, Burg G, Künzi W, Meuli-Simmen C, Neff P, Meyer V, Mihic D, Garzoli E, Jungius KP, Seifert B, Dummer R, Steinert H.

Br J Dermatol. 2004 Apr;150(4):677-86.

PMID:
15099363
18.

Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma.

Havenga K, Cobben DC, Oyen WJ, Nienhuijs S, Hoekstra HJ, Ruers TJ, Wobbes T.

Eur J Surg Oncol. 2003 Oct;29(8):662-4.

PMID:
14511614
19.

Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.

Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N, Bouchelouche K.

Scand J Urol Nephrol. 2011 Mar;45(2):122-8. doi: 10.3109/00365599.2010.544672. Epub 2011 Jan 13.

PMID:
21231796
20.

Whole-body 18 FDG PET/CT imaging for lymph node and metastatic staging of conjunctival melanoma.

Kurli M, Chin K, Finger PT.

Br J Ophthalmol. 2008 Apr;92(4):479-82. doi: 10.1136/bjo.2007.124339.

PMID:
18369064
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk